GlassScriptPhysician profile
Neelima Katragunta
NPI 1912188236
$27,042.00
in general payments reported to CMS, 2019-2025
27 companies · $18K in 2025
The $18K reported for 2025 was more than what 94% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,979 · 2021: $1,236 · 2022: $1,998 · 2023: $1,803 · 2024: $2,461 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $8,199 · Travel and Lodging: $2,611 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,800.00 |
| Food and Beverage | $8,198.91 |
| Travel and Lodging | $2,610.74 |
| Education | $219.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $13,278.63 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $4,249.13 | 2022-2025 | Indigo System, Penumbra System, Smart Coil |
| Silk Road Medical, INC. | $1,840.47 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $1,595.84 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $1,543.43 | 2021-2025 | Protege Rx, Hawkone, Endurant Iis |
| Abbott Laboratories | $565.89 | 2021-2025 | Esprit, Perclose Proglide, Aveir |
| Inari Medical, INC. | $563.75 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $494.82 | 2019-2024 | Zenith |
| Endologix LLC | $421.36 | 2025 | Afx2 Bifurcated Endograft System |
| Medtronic Vascular, INC. | $401.58 | 2019 | |
| Stryker Corporation | $300.03 | 2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bolton Medical INC | $298.91 | 2022-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Smith+Nephew, INC. | $286.37 | 2021-2022 | |
| Boston Scientific Corporation | $277.86 | 2024-2025 | Eluvia, Ekosonic, Enroute Transcarotid Neuroprotection System |
| Ge Healthcare | $145.80 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $125.00 | 2021 | |
| Cordis US Corp. | $120.49 | 2021-2023 | Brite Tip Radianz |
| Bard Peripheral Vascular, INC. | $114.48 | 2025 | Venovo |
| Terumo Medical Corporation | $112.68 | 2023 | Azur Cx Detachable, Angio-Seal |
| Janssen Pharmaceuticals, INC | $65.53 | 2021-2023 | Xarelto |
| Lemaitre Vascular, INC. | $47.94 | 2022-2025 | Hydro Lemaitre Valvulotome |
| Ethicon US, LLC | $46.57 | 2024 | Dermabond, Prolene, Ethicon |
| Camber Spine Technologies LLC | $41.95 | 2021 | |
| Philips North America LLC | $36.13 | 2024-2025 | Igt Devices Systems Undivided, (Br5) Peripheral Ivus |
| Osiris Therapeutics INC. | $35.32 | 2019 | |
| Cardiva Medical, INC. | $28.33 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cardiovascular Systems INC. | $3.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neelima Katragunta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.